GAMMA Investing LLC Has $17.74 Million Position in The Cooper Companies, Inc. (NASDAQ:COO)

GAMMA Investing LLC lifted its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 5,733.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 210,285 shares of the medical device company's stock after acquiring an additional 206,680 shares during the quarter. GAMMA Investing LLC owned 0.11% of Cooper Companies worth $17,738,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the stock. Wellington Management Group LLP boosted its position in shares of Cooper Companies by 517.1% in the 4th quarter. Wellington Management Group LLP now owns 175,152 shares of the medical device company's stock valued at $16,102,000 after purchasing an additional 146,771 shares during the period. Wealth Enhancement Advisory Services LLC lifted its stake in Cooper Companies by 3.4% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 9,370 shares of the medical device company's stock valued at $861,000 after buying an additional 309 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in Cooper Companies during the fourth quarter valued at about $17,392,000. Jefferies Financial Group Inc. boosted its holdings in shares of Cooper Companies by 138.9% in the fourth quarter. Jefferies Financial Group Inc. now owns 48,514 shares of the medical device company's stock worth $4,460,000 after buying an additional 28,204 shares during the period. Finally, Mackenzie Financial Corp increased its position in shares of Cooper Companies by 12.4% in the fourth quarter. Mackenzie Financial Corp now owns 19,910 shares of the medical device company's stock worth $1,830,000 after acquiring an additional 2,193 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Stock Up 1.6%

COO traded up $1.15 during trading on Friday, reaching $72.33. 4,093,480 shares of the stock traded hands, compared to its average volume of 1,591,956. The stock's 50-day simple moving average is $78.35 and its two-hundred day simple moving average is $87.39. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The Cooper Companies, Inc. has a fifty-two week low of $65.00 and a fifty-two week high of $112.38. The stock has a market cap of $14.46 billion, a price-to-earnings ratio of 37.09, a price-to-earnings-growth ratio of 2.25 and a beta of 0.98.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.93 by $0.03. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business had revenue of $1 billion during the quarter, compared to analyst estimates of $995.12 million. During the same period in the previous year, the company earned $0.85 EPS. The firm's revenue was up 6.3% on a year-over-year basis. As a group, equities research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages recently commented on COO. Robert W. Baird reduced their price target on shares of Cooper Companies from $107.00 to $97.00 and set an "outperform" rating for the company in a research report on Friday, May 30th. BNP Paribas upgraded Cooper Companies to a "hold" rating in a report on Thursday, March 13th. JPMorgan Chase & Co. reiterated a "neutral" rating and set a $76.00 price target (down previously from $110.00) on shares of Cooper Companies in a report on Friday, May 30th. Stifel Nicolaus dropped their price target on Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. Finally, Piper Sandler restated an "overweight" rating and set a $105.00 price objective (down from $115.00) on shares of Cooper Companies in a research report on Friday, May 30th. Five analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $100.38.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.